关注
Amir Ajoolabady
Amir Ajoolabady
其他姓名Just a mediocre for now but will rise to the status I truly deserve
Scientific Thinker, Critic, Debater & Theorist - University of Alabama at Birmingham
在 uab.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Ferritinophagy and Ferroptosis in the Management of Metabolic Diseases
A Ajoolabady, H Aslkhodapasandhokmabad, P Libby, J Tuomilehto, ...
Trends in Endocrinology & Metabolism, 2021
1832021
Targeting Autophagy in Ischemic Stroke: from Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, S Wang, G Kroemer, JM Penninger, VN Uversky, D Pratico, ...
Pharmacology & Therapeutics, 2021
1402021
Endoplasmic Reticulum Stress in Liver Diseases
A Ajoolabady, N Kaplowitz, C Lebeaupin, G Kroemer, RJ Kaufman, ...
Hepatology, 2023
1092023
FUNDC1 Interacts with FBXL2 to Govern Mitochondrial Integrity and Cardiac Function through an IP3R3-Dependent Manner in Obesity
J Ren, M Sun, H Zhou, A Ajoolabady, Y Zhou, J Tao, JR Sowers, Y Zhang
Science Advances, 2020
932020
FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly through ACSL4-Mediated Ferroptosis
Z Pei, Y Liu, S Liu, W Jin, Y Luo, M Sun, Y Duan, A Ajoolabady, J Sowers, ...
Metabolism, 2021
902021
ER Stress and UPR in Alzheimer's Disease: Mechanisms, Pathogenesis, Treatment
A Ajoolabady, D Lindholm, J Ren, D Pratico
Cell Death & Disease - Nature, 2022
812022
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing
A Ajoolabady, H Aslkhodapasandhokmabad, A Aghanejad, Y Zhang, ...
Ageing Research Reviews, 2020
762020
Mitophagy in Cardiovascular Diseases: Molecular Mechanisms, Pathogenesis, and Treatment
A Ajoolabady, M Chiong, S Lavandero, DJ Klionsky, J Ren
Trends in Molecular Medicine, 2022
662022
ER Stress in Obesity Pathogenesis and Management
A Ajoolabady, S Liu, DJ Klionsky, GYH Lip, J Tuomilehto, S Kavalakatt, ...
Trends in Pharmacological Sciences, 2022
602022
ER Stress in Cardiometabolic Diseases: from Molecular Mechanisms to Therapeutics
A Ajoolabady, S Wang, G Kroemer, DJ Klionsky, VN Uversky, JR Sowers, ...
Endocrine Reviews, 2021
482021
Enzyme-Based Autophagy in Anti-Neoplastic Management: from Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, A Aghanejad, Y Bi, Y Zhang, H Aslkhodapasandhukmabad, ...
BBA-Reviews on Cancer, 2020
482020
Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review
A Ajoolabady, S Nattel, GYH Lip, J Ren
Journal of the American College of Cardiology, 2022
462022
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
N Rostami, A Nikkhoo, A Ajoolabady, G Azizi, M Hojjat-Farsangi, ...
Molecular Diagnosis & Therapy, 2019
462019
Multifunctional Nanomedicines for Targeting Epidermal Growth Factor Receptor in Colorectal Cancer
A Ajoolabady
Cellular and Molecular Life Sciences, 2020
42*2020
Dysregulation of Iron Metabolism in Cardiovascular Diseases: From Iron Deficiency to Iron Overload
Y Bi, A Ajoolabady, LJ Demillard, W Yu, ML Hilaire, Y Zhang, J Ren
Biochemical Pharmacology, 2021
412021
Ferroptosis in Hepatocellular Carcinoma: Mechanisms and Targeted Therapy
A Ajoolabady, D Tang, G Kroemer, J Ren
British journal of cancer - Nature, 2023
382023
Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy
V Hashemi, S Farhadi, MG Chaleshtari, B Seashore-Ludlow, A Masjedi, ...
International Immunopharmacology, 2020
312020
FUNDC1 Interacts with GPX4 to Govern Hepatic Ferroptosis and Fibrotic Injury through a Mitophagy-Dependent Manner
Y Bi, S Liu, X Qin, M Abudureyimu, L Wang, R Zou, A Ajoolabady, ...
Journal of Advanced Research, 2024
292024
Chitosan-Based Nanotherapeutics for Ovarian Cancer Treatment
L Alizadeh, A Zarebkohan, R Salehi, A Ajoolabady, M Rahmati-Yamchi
Journal of Drug Targeting, 2019
292019
ER Stress and Inflammation Crosstalk in Obesity
A Ajoolabady, C Lebeaupin, NN Wu, RJ Kaufman, J Ren
Medicinal Research Reviews, 2023
282023
系统目前无法执行此操作,请稍后再试。
文章 1–20